Node-positive prostate cancer: a call for level 1 evidence.

Alberto Briganti, R. Jeffrey Karnes, Luigi Filippo Da Pozzo, Cesare Cozzarini, Umberto Capitanio, Andrea Gallina, Nazareno Suardi, Marco Bianchi, Manuela Tutolo, Andrea Salonia, Nadia Di Muzio, Patrizio Rigatti, Francesco Montorsi, Michael Blute, Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis European Urology. ,vol. 59, pp. 832- 840 ,(2011) , 10.1016/J.EURURO.2011.02.024

Jonathan D. Tward, Kristine E. Kokeny, Dennis C. Shrieve, Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival Practical radiation oncology. ,vol. 3, pp. 234- 240 ,(2013) , 10.1016/J.PRRO.2012.11.011

Roland Seiler, Urs E. Studer, Konrad Tschan, Pia Bader, Fiona C. Burkhard, Removal of Limited Nodal Disease in Patients Undergoing Radical Prostatectomy: Long-Term Results Confirm a Chance for Cure Journal of Urology. ,vol. 191, pp. 1280- 1285 ,(2014) , 10.1016/J.JURO.2013.11.029

Gunar K Zagars, Alan Pollack, Andrew C von Eschenbach, Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. ,vol. 58, pp. 233- 239 ,(2001) , 10.1016/S0090-4295(01)01168-2

Anders Widmark, Olbjørn Klepp, Arne Solberg, Jan-Erik Damber, Anders Angelsen, Per Fransson, Jo-Åsmund Lund, Ilker Tasdemir, Morten Hoyer, Fredrik Wiklund, Sophie D Fosså, Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial The Lancet. ,vol. 373, pp. 301- 308 ,(2009) , 10.1016/S0140-6736(08)61815-2

Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham, Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy European Urology. ,vol. 65, pp. 20- 25 ,(2014) , 10.1016/J.EURURO.2013.03.053

Thomas Wiegel, Dirk Bottke, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Norman Willich, Axel Semjonow, Rainer Souchon, Michael Stöckle, Christian Rübe, Lothar Weißbach, Peter Althaus, Udo Rebmann, Tilman Kälble, Horst Jürgen Feldmann, Manfred Wirth, Axel Hinke, Wolfgang Hinkelbein, Kurt Miller, Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95 Journal of Clinical Oncology. ,vol. 27, pp. 2924- 2930 ,(2009) , 10.1200/JCO.2008.18.9563

Edward M Messing, Judith Manola, Jorge Yao, Maureen Kiernan, David Crawford, George Wilding, P Anthony di'SantAgnese, Donald Trump, Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncology. ,vol. 7, pp. 472- 479 ,(2006) , 10.1016/S1470-2045(06)70700-8

Alberto Briganti, Firas Abdollah, Alessandro Nini, Nazareno Suardi, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Manuela Tutolo, Niccolò Maria Passoni, Andrea Salonia, Renzo Colombo, Massimo Freschi, Patrizio Rigatti, Francesco Montorsi, Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection European Urology. ,vol. 61, pp. 1132- 1138 ,(2012) , 10.1016/J.EURURO.2011.11.008

Padraig Warde, Malcolm Mason, Keyue Ding, Peter Kirkbride, Michael Brundage, Richard Cowan, Mary Gospodarowicz, Karen Sanders, Edmund Kostashuk, Greg Swanson, Jim Barber, Andrea Hiltz, Mahesh KB Parmar, Jinka Sathya, John Anderson, Charles Hayter, John Hetherington, Matthew R Sydes, Wendy Parulekar, Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial The Lancet. ,vol. 378, pp. 2104- 2111 ,(2011) , 10.1016/S0140-6736(11)61095-7